The University of Southampton
University of Southampton Institutional Repository

The role of OX40-OX40L interactions in experimental colitis

The role of OX40-OX40L interactions in experimental colitis
The role of OX40-OX40L interactions in experimental colitis

Mice with TNBS colitis were treated with OX40 fusion proteins designed to have different effector functions in vivo (human OX40 fused to the constant region of human IgG1, and human OX40 fused to human IgG4 where Leu235 had been mutated to Glu to produce a fusion protein which could no fix complement and is reduced in its ability to mediate ADCC).  Each construct was equally effective at reducing the CD4 cell infiltrate and TNFα transcript numbers in the colon of mice with TNBS colitis.  In addition the efficacy of adenoviruses expressing soluble OX40 and OX40-IgG1 were also tested, and each were identically efficacious in ameliorating TNBS colitis.  To extend this work into other models of colitis, OX40-IgG also reduced inflammation in colitis caused by infection with the bacterium Citrobacter rodentium.

Since OX40 is expressed on cells in the gut of mice with TNBS colitis and C. rodentium induced colitis, mice were treated with an OX40L-IgG fusion protein, in an attempt to deliver a co-stimulatory signal in vivo.  In both cases, OXj40L-IgG treatment exacerbated inflammation.  As part of this work however it was discovered that OX40 was present on T cells in normal colon.  When normal mice were repeatedly injected with OX40L-IgG, they developed a mild colitis.

In the final part of the thesis, the issue of whether OX40-IgG ameliorates inflammation by blocking extravasation of T cells from the gut into the blood was addressed.  When CFSE labelled mesenteric node cells were transferred into mice with TNBS colitis, transferred cells could be recovered from the colon and organised lymphoid tissue 24 hours later.  Injection of recipients with OX40-IgG substantially reduced the recovery of labelled cells, strongly suggesting that a blockade of homing to the gut plays a role in the therapeutic effects of OX40 fusion proteins.

University of Southampton
Bachler, Marcus A
Bachler, Marcus A

Bachler, Marcus A (2003) The role of OX40-OX40L interactions in experimental colitis. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Mice with TNBS colitis were treated with OX40 fusion proteins designed to have different effector functions in vivo (human OX40 fused to the constant region of human IgG1, and human OX40 fused to human IgG4 where Leu235 had been mutated to Glu to produce a fusion protein which could no fix complement and is reduced in its ability to mediate ADCC).  Each construct was equally effective at reducing the CD4 cell infiltrate and TNFα transcript numbers in the colon of mice with TNBS colitis.  In addition the efficacy of adenoviruses expressing soluble OX40 and OX40-IgG1 were also tested, and each were identically efficacious in ameliorating TNBS colitis.  To extend this work into other models of colitis, OX40-IgG also reduced inflammation in colitis caused by infection with the bacterium Citrobacter rodentium.

Since OX40 is expressed on cells in the gut of mice with TNBS colitis and C. rodentium induced colitis, mice were treated with an OX40L-IgG fusion protein, in an attempt to deliver a co-stimulatory signal in vivo.  In both cases, OXj40L-IgG treatment exacerbated inflammation.  As part of this work however it was discovered that OX40 was present on T cells in normal colon.  When normal mice were repeatedly injected with OX40L-IgG, they developed a mild colitis.

In the final part of the thesis, the issue of whether OX40-IgG ameliorates inflammation by blocking extravasation of T cells from the gut into the blood was addressed.  When CFSE labelled mesenteric node cells were transferred into mice with TNBS colitis, transferred cells could be recovered from the colon and organised lymphoid tissue 24 hours later.  Injection of recipients with OX40-IgG substantially reduced the recovery of labelled cells, strongly suggesting that a blockade of homing to the gut plays a role in the therapeutic effects of OX40 fusion proteins.

This record has no associated files available for download.

More information

Published date: 2003

Identifiers

Local EPrints ID: 465217
URI: http://eprints.soton.ac.uk/id/eprint/465217
PURE UUID: 290ef33d-471d-408e-934e-98618f1c3af7

Catalogue record

Date deposited: 05 Jul 2022 00:29
Last modified: 05 Jul 2022 00:29

Export record

Contributors

Author: Marcus A Bachler

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×